-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
Can Vonn defy ACL rupture to win Olympic medal?
-
Breakthrough or prelude to attack? What we know about Iran-US talks
-
German far-right MP detained over alleged Belarus sanctions breach
-
MSF says its hospital in South Sudan hit by government air strike
-
Merz heads to Gulf as Germany looks to diversify trade ties
-
Selection process for future Olympic hosts set for reform
-
Serbian minister on trial over Trump-linked hotel plan
-
UK PM says Mandelson 'lied', regrets appointing him US envoy
-
Cochran-Siegle tops first Olympic downhill training
-
Gaza health officials say strikes kill 21 after Israel says shots wounded officer
-
Injured Vonn's Olympic bid is 'inspirational', ski stars say
-
Albania arrests 20 for toxic waste trafficking
-
US-Africa trade deal renewal only 'temporary breather'
-
Mir sets pace on Sepang day two, Yamaha absent
-
Xi, Putin hail 'stabilising' China-Russia alliance
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Sky is the limit for Ireland fly-half Prendergast, says captain Doris
-
Stocks fluctuate after Wall St AI-fuelled sell-off
-
Feyi-Waboso reminds England great Robinson of himself
-
Starmer faces MPs as pressure grows over Mandelson scandal
-
HRW urges pushback against 'aggressive superpowers'
-
Russia demands Ukraine give in as UAE talks open
-
Gaza civil defence says 17 killed in strikes after Israel says shots wounded officer
-
France's Kante joins Fenerbahce after Erdogan 'support'
-
CK Hutchison launches arbitration over Panama Canal port ruling
-
Stocks mostly rise as traders ignore AI-fuelled sell-off on Wall St
-
Acclaimed Iraqi film explores Saddam Hussein's absurd birthday rituals
-
On rare earth supply, Trump for once seeks allies
-
Ukrainian chasing sumo greatness after meteoric rise
-
Draper to make long-awaited return in Davis Cup qualifier
-
Can Ilia Malinin fulfil his promise at the Winter Olympics?
-
CK Hutchison begins arbitration against Panama over annulled canal contract
-
UNESCO recognition inspires hope in Afghan artist's city
-
Ukraine, Russia, US negotiators gather in Abu Dhabi for war talks
-
WTO must 'reform or die': talks facilitator
-
Doctors hope UK archive can solve under-50s bowel cancer mystery
-
Stocks swing following latest AI-fuelled sell-off on Wall St
-
Demanding Dupont set to fire France in Ireland opener
-
Britain's ex-prince Andrew leaves Windsor home: BBC
-
Coach plots first South Africa World Cup win after Test triumph
-
Spin-heavy Pakistan hit form, but India boycott risks early T20 exit
-
Japan eyes Premier League parity by aligning calendar with Europe
-
Whack-a-mole: US academic fights to purge his AI deepfakes
-
Love in a time of war for journalist and activist in new documentary
-
'Unprecedented mass killing': NGOs battle to quantify Iran crackdown scale
-
Seahawks kid Cooper Kupp seeks new Super Bowl memories
-
Thousands of Venezuelans march to demand Maduro's release
-
AI, manipulated images falsely link some US politicians with Epstein
US baby formula shortage could last for some time: official
The nationwide shortage of baby formula in the United States could last for some time, a top White House economic adviser cautioned on Friday.
The problem "is not going to solve itself in a day or week," Brian Deese told CNN.
US families have grown increasingly desperate for formula amid a perfect storm of supply issues compounded by a massive recall.
While he would not offer a specific timeline, Deese said, "We are looking at every possible angle that we can to try to address this issue."
The average out-of-stock rate for baby formula last week hit 43 percent, according to Datasembly, which collected information from more than 11,000 retailers.
The scarcity initially was caused by supply chain problems and labor shortages, but the problem has been worsening since February 17 when manufacturer Abbott announced a "voluntary recall" for formula made at its factory in Michigan after the death of two infants,.
That recall included Similac, a brand used by millions of American families.
A subsequent investigation cleared the formula, but production has yet to resume.
"We've got to see how this progresses in real time," Deese said.
It is the latest crisis to confound President Joe Biden's push to get the US economy on sound footing amid the highest inflation in four decades and the ongoing global supply chain bottlenecks.
The United States produces about 98 percent of the formula it consumes, and the Biden administration plans to increase imports of the powdered milk.
"The most important step that we can take right now is to give retailers more flexibility on the types of formula that they can sell, and consumers more flexibility for the types that they can buy," Deese said.
Officials also are working with manufacturers and he noted that domestic output has been recovering.
Over the past month "there has been more production of formula than there was in the weeks preceding the recall," Deese said.
W.AbuLaban--SF-PST